Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Real Betis updates Álvaro Vallés after the sale of the goalkeeper

In the coming days, Real Betis will close the sale of Rui Silva, who will arrive on loan to Sporting CP with an obligation to purchase in the summer. Understandably, there has been talk that he will be replaced by Álvaro Valles, who will almost certainly return to Los Verdiblancos sometime in 2025.

Valles has been ostracized at Las Palmas after refusing to sign a new contract, and has taken this stance to ensure he joins Betis when his current contract expires at the end of the season. It has been suggested that he make the move this month due to Silva’s departure, but that will not happen.

Betis sporting director Manu Fajardo has confirmed that Valles will not join in January, according to ED.

“Right now the sale of Rui Silva is being carried out, which is a sale that we understood was good for all parties and now, we will continue working until the last day of the market. I have no intention of visiting the Canary Islands (through Valles). I know that life is very good there and I wish all the luck in the world to the Canarian teams, but I am not going to move from Seville.”

As such, it means that Fran Vieites will continue as Betis’ starter in La Liga, while Adrián San Miguel should continue in the Copa del Rey and UEFA Conference League.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.